Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction North China Pharmaceutical Co., Ltd. (hereinafter referred to as North China Pharmaceutical) is one of the large chemical pharmaceutical enterprises in China. In August 1992, with North China Pharmaceutical Factory as the initiator, it invested all its production and operational assets and raised shares from internal employees to form a joint stock limited company. North China Pharmaceutical Factory is a key construction project during China's "First Five Year Plan" period. It was established in 1953 and completed and put into operation in 1958, ending China's history of relying on imports of penicillin and streptomycin, making important contributions to changing the situation of medical shortage in China. On January 14, 1994, North China Pharmaceutical was officially listed and traded on the Shanghai Stock Exchange (stock code 600812, stock abbreviation "North China Pharmaceutical"). North China Pharmaceutical currently has 6 branches, 21 wholly-owned subsidiaries, and 5 holding subsidiaries. Mainly engaged in the research and development, production, and sales of pharmaceutical products. North China Pharmaceutical products involve chemical drugs, biopharmaceuticals, health consumer goods, and more. The treatment field covers over 700 product specifications, including anti infective drugs, cardiovascular and cerebrovascular drugs, kidney and immune regulatory drugs, tumor treatment drugs, vitamins, and health consumer goods.
Headquarter Shijiazhuang
Establish Date 12/20/1992
Listed Code 600812.SH
Listed Date 1/14/1994
Chairman Xiao Mingjian.
CEO Liu Xinyan.
Website www.ncpc.cn

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial